Substance-induced sleep disorders and abuse of hypnotics;Substanzinduzierte schlafstörungen und schlafmittelmissbrauch

Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz

Volumn 54, Issue 12, 2011, Pages 1325-1331

  Riemann, D ^a   Nissen, C ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Abuse of hypnotics; Hypnotics; Illicit drugs; Recreational drugs; Sleep disrupting drugs

Indexed keywords

BENZODIAZEPINE DERIVATIVE; HYPNOTIC SEDATIVE AGENT;

ADDICTION; ARTICLE; CHEMICALLY INDUCED DISORDER; HUMAN; SLEEP DISORDER;

BENZODIAZEPINES; HUMANS; HYPNOTICS AND SEDATIVES; SLEEP DISORDERS; SUBSTANCE-RELATED DISORDERS;

EID: 84856084476     PISSN: 14369990     EISSN: 14371588     Source Type: Journal    
DOI: 10.1007/s00103-011-1374-2     Document Type: Article

References (48)

1. Basheer R, Strecker RE, Thakkar MH, McCarley RW (2004) Adenosine and sleep-wake regulation. Prog Neurobiol 73:379-396 (Pubitemid 39094087)
2. Roehrs T, Roth T (2008) Caffeine: sleep and daytime sleepiness. Sleep Med Rev 12:153-162 (Pubitemid 351374841)
3. Riemann D, Spiegelhalder K, Feige B et al (2010) The hyperarousal model of insomnia: a review of the concept and its evidence. Sleep Med Rev 14:19-31
4. DHS (2010) Jahrbuch Sucht. Neuland Verlagsgesellschaft mbh, Geesthacht
5. Jaehne A, Loessl B, Barkai Z et al (2009) Effects of nicotine on sleep during consumption, withdrawal and replacement therapy. Sleep Med Rev 13:363-377
6. Gann H, Calker D van, Feige B, Riemann D (2004) Die Bedeutung des Schlafs für gesunde Alkoholkonsumenten und alkoholabhängige Patienten. Nervenarzt 75:431-441 (Pubitemid 38724458)
7. National Institute on Drug Abuse (2006) Monitoring the future. National results on adolescent drug use. Overview of key findings 2006. Online, cited 2007, Sep. 10, 76 screens. http://www.monitoringthefuture.org/
8. Schierenbeck T, Riemann D, Berger M, Hornyak M (2008) Effect of illicit recreational drugs upon sleep: cocaine, ecstasy and marijuana. Sleep Med Rev 12:381-390
9. Dahlöf C, Dimenäs E (1990) Side effects of betablocker treatments as related to the central nervous system. Am J Med Sci 299:236-244 (Pubitemid 20118924)
10. McAinsh J, Cruickshank JM (1990) Beta-blockers and central nervous system side effects. Pharmacol Ther 46:163-197 (Pubitemid 20094960)
11. Kanno O, Clarenbach P (1985) Effect of clonidine and yohimbine on sleep in man: polygraphic study and EEG analysis by normalized slope descriptors. Electroencephalogr Clin Neurophysiol 60(6):478-484 (Pubitemid 15022805)
12. Monti JM (1987) Disturbances of sleep and wakefulness associated with the use of antihypertensive agents. Life Sci 41:1979-1988 (Pubitemid 18006126)
13. Buckley TM, Schatzberg AF (2005) On the interactions of the hypothalamic-pituitary-adrenal (HPA) axis and sleep: normal HPA axis activity and circadian rhythm, exemplary sleep disorders. J Clin Endocrinol Metab 90:3106-3114 (Pubitemid 40686371)
14. Van Cauter E, Turek FW (1995) Endocrine and other biological rhythms. In: De Groot LJ (Hrsg) Endocrinology, 3. Aufl. Saunders, Philadelphia, S 2497-2548
15. Friess E, Tagaya H, Grethe C et al (2004) Acute cortisol administration promotes sleep intensity in man. Neuropsychopharmacology 29:598-604 (Pubitemid 38365937)
16. Bradbury MJ, Dement WC, Edgar DM (1998) Effects of adrenalectomy and subsequent corticosterone replacement on rat sleep state and EEG power spectra. Am J Physiol 275:R555-R565
17. McDonough AK, Curtis JR, Saag KG (2008) The epidemiology of glucocorticoid-associated adverse events. Curr Opin Rheumatol 20:131-137 (Pubitemid 351339883)
18. Cairns BE (2007) Pain medication and sleep quality. In: Lavigne G, Sessle BJ, Choiniere M, Soja PJ (Hrsg) Sleep and pain. IASP press, Seattle, S 371-390
19. Agargun MY, Ozbek H (2006) Drug effects on dreaming. In: Lader M, Cardinali DP, Pandi-Perumal SR (Hrsg) Sleep and sleep disorders: a neuropsychopharmacological approach. Landes Bioscience/Eurekah.com and Springer Science+Business Media, New York, S 256-261
20. Riemann D, Voderholzer U (2003) der gestörte Schlaf: Via regia zum Verständnis depressiver Erkrankungen. Uni-Med., Bremen
21. Hoque R, Chesson AL (2010) Pharmacologically induced/exacerbated restless legs syndrome, periodic limb movements of sleep, and REM behavior disorder/REM sleep without atonia: literature review, qualitative scoring, and comparative analysis. J Clin Sleep Med 6:79-83
22. Riemann D, Hajak G (2009) Insomnien. II. Pharmakologische und psychotherapeutische Behandlungsmöglichkeiten. Nervenarzt 80:1327-1340
23. Benkert O, Hippius H (2007) Kompendium der Psychiatrischen Pharmakotherapie. Springer, Berlin Heidelberg New York Tokyo
24. Mendelson WB (2005) Hypnotic medications: mechanisms of action and pharmacological effects. In: Kryger MH, Roth T, Dement WC (Hrsg) Principles and practice of sleep medicine, 4. Aufl. Elsevier Saunders, Philadelphia PA, S 444-451
25. Riemann D, Perlis ML (2009) The treatments of chronic insomnia: a review of benzodiazepine receptor agonists and psychological and behavioral therapies. Sleep Med Rev 13:205-214
26. Krystal AD, Walsh JK, Laska E et al (2003) Sustained efficacy of eszopiclone over 6 months of nightly treatment: results of a randomized, double-blind, placebo-controlled study in adults with chronic insomnia. Sleep 26:793-799 (Pubitemid 39610622)
27. Krystal AD, Erman M, Zammit GK et al (2008) Longterm efficacy and safety of zolpidem extended-release 12, 5 mg, administered 3-7 nights per week for 24 weeks, in patients with chronic primary insomnia: a 6-month, randomized, double-blind, placebo-controlled, parallel-group, multicenter study. Sleep 31:79-90
28. Holbrook AM, Crowther R, Lotter A et al (2000) Meta-analysis of benzodiazepine use in the treatment of insomnia. CMAJ 162:225-233 (Pubitemid 30073249)
29. Glass J, Lanctot KL, Herrmann N et al (2005) Sedative hypnotics in older people with insomnia: meta-analysis of risks and benefits. BMJ 331:1169-1175
30. Hippius H, Engel RR, Laakmann G (1986) Benzodiazepine - Rückblick und Ausblick. Springer, Berlin Heidelberg New York Tokyo
31. Hajak G, Rüther E (1995) Insomnie. Springer, Berlin Heidelberg New York Tokyo
32. Terzano MG, Rossi M, Palomba V et al (2003) New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon. Drug Saf 26:261-282 (Pubitemid 36363607)
33. Vermeeren A (2004) Residual effects of hypnotics: epidemiology and clinical implications. CNS Drugs 18:297-328 (Pubitemid 38526714)
34. Verster JC, Veldhuijzen DS, Patar A et al (2006) Hypnotics and driving safety: meta-analyses of randomized controlled trials applying the on-theroad driving test. Curr Drug Saf 1:63-71
35. Verster JC, Mets MA (2009) Psychoactive medication and traffic safety. Int J Environ Res Public Health 6:1041-1054
36. Kripke DF, Garfinkel I, Wingard DL (2002) Mortality associated with sleep duration and insomnia. Arch Gen Psychiatry 59:131-136 (Pubitemid 34137380)
37. Kripke DF (2006) Risks of chronic hypnotic use. In: Lader M, Cardinali DP, Pandi-Perumal SR (Hrsg) Sleep and sleep disorders - a neuropsychopharmacologuical approach. Springer, New York, S141-145
38. Schwabe U, Pfaffrath D (2008) Arzneiverordnungsreport 2008. Springer, Berlin
39. Hoffmann F, Scharfetter W, Glaeske G (2009) Use of zolpidem and zopiclone on private prescriptions between 1993 and 2007. Nervenarzt 80:578-583
40. Hoffmann F, Hies M, Gläske G (2010) Regional variations of private prescriptions for the non-benzodiazepine hypnotics zolpidem and zopiclone in Germany. Pharmacoepidemiol Drug Saf 19:1071-1077
41. Hajak G, Müller WE, Wittchen HU et al (2003) Abuse and depen-dence potential for the non-benzodiazepine hypnotics Zolpidem and Zopiclone - a review of case reports and epidemiological data. Addiction 98:1371-1378 (Pubitemid 37297243)
42. Lange K, Wodarz N, Hajak G (2007) Abhängigkeitspotential der GABAa-Rezeptor-agonistischen Nichtbenzodiazepin-Hypnotika. Sucht 53:201-213
43. Victorri-Vigneau C, Dailly E, Veyrac G, Jolliet P (2007) Evidence of zolpidem abuse and dependence: results of the French Centre for Evaluation and Information on Pharmacodependence (CEIP) network survey. Br J Clin Pharmacol 64:198-209 (Pubitemid 47063241)
44. Krämer K, Nolting HD (2010) Gesundheitsreport 2010 - DAK. Medhochzwei, Heidelberg
45. Gläske G (2010) Medikamente - Psychotrope und andere Arzneimittel mit Missbrauchs-und Abhängigkeitspotential. Jahrbuch Sucht (DHS) Neuland Verlagsgesellschaft mbH, Geesthacht, S 69-95
46. Hohagen F, Käppler C, Schramm E et al (1994) Prevalence of insomnia in elderly general practice attenders and the current treatment modalities. Acta Psychiatr Scand 90:102-108 (Pubitemid 24246321)
47. Riemann D, Spiegelhalder K, Espie C et al (2011) Chronic insomnia: clinical and research challenges - an agenda. Pharmacopsychiatry 44:1-14
48. Wiegand M (2008) Antidepressants for the treatment of insomnia - A suitable approach? Drugs 68:2411-2417